MoneyWorks4Me

The March 2025 quarter revenue stood at Rs. 9013.40 millions, up 11.39% as compared to Rs. 8092.00 millions during the corresponding quarter last year.A slim rise of 19.03% was recorded in the Net profit for the quarter ended March 2025 to Rs. 1498.00  millions  From Rs. 1258.50 millions.Operating Profit saw a handsome growth to 2445.10 millions from 2111.50 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 9013.40 8092.00 11.39 37229.20 32986.40 12.86 37229.20 32986.40 12.86
Other Income 135.30 161.00 -15.96 347.40 346.80 0.17 347.40 346.80 0.17
PBIDT 2445.10 2111.50 15.80 10526.80 9141.00 15.16 10526.80 9141.00 15.16
Interest 9.30 83.20 -88.82 91.20 405.20 -77.49 91.20 405.20 -77.49
PBDT 2435.80 2028.30 20.09 10435.60 8735.80 19.46 10435.60 8735.80 19.46
Depreciation 444.10 397.20 11.81 1664.50 1352.40 23.08 1664.50 1352.40 23.08
PBT 1991.70 1631.10 22.11 8771.10 7383.40 18.79 8771.10 7383.40 18.79
TAX 493.70 372.60 32.50 2245.70 1949.80 15.18 2245.70 1949.80 15.18
Deferred Tax 57.80 93.40 -38.12 328.80 494.90 -33.56 328.80 494.90 -33.56
PAT 1498.00 1258.50 19.03 6525.40 5433.60 20.09 6525.40 5433.60 20.09
Equity 155.70 155.20 0.32 155.70 155.20 0.32 155.70 155.20 0.32
PBIDTM(%) 27.13 26.09 3.96 28.28 27.71 2.04 28.28 27.71 2.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..